ClinicalTrials.gg

Wockhardt clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 43 studies whose lead sponsor is Wockhardt or one of 1 company grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Wockhardt with Qilu Pharmaceutical and Jiangsu HengRui Medicine →

Pipeline: 5 programs

Each counted once: 5 with a study Wockhardt leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Wockhardt’s own registered studies; Wockhardt’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Wockhardt’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Wockhardt’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 43 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now37%
  • Completed3377%
  • Stopped early614%Withdrawn 5 · Terminated 1
  • Status unknown or other12%

Phase

  • Phase 130
  • Phase 39
  • Phase 22
  • Phase 42

Where

  • United States30
  • India5
  • France3
  • Poland2
  • Bulgaria2
  • Lithuania2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 711
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Wockhardt.

  • Wockhardt
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    39 studies
  • Laboratoires NEGMA
    Acquired — became part of Wockhardt, May 17, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →

Studies

Recruiting first, then most recently updated. Showing 43 of 43.